-
Signature
-
/s/ Jonathan Allan, Attorney-in-Fact
-
Issuer symbol
-
STOK
-
Transactions as of
-
13 Mar 2026
-
Net transactions value
-
-$22,264
-
Form type
-
4
-
Filing time
-
17 Mar 2026, 17:23:01 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| LEVIN ARTHUR A |
Director |
C/O STOKE THERAPEUTICS, INC., 45 WIGGINS AVENUE, BEDFORD |
/s/ Jonathan Allan, Attorney-in-Fact |
17 Mar 2026 |
0001181556 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
STOK |
Common Stock |
Sale |
$22,264 |
-605 |
-12% |
$36.80 |
4,237 |
13 Mar 2026 |
Direct |
F1 |
| holding |
STOK |
Common Stock |
|
|
|
|
|
17,979 |
13 Mar 2026 |
Arthur A. Levin, Ph.D., Trustee, Butler-Levin Revocable Trust |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: